Most people have never heard of the U.S. Preventive Services Task Force. It decides which screenings your insurer must cover at no cost to you. That power came from the Affordable Care Act. So when the health secretary named a new slate of specialists to the panel, 17 Democratic senators wrote him a letter. The Journal's editorial board wrote a column about the letter. Both sides are really arguing about money.
Here's how the plumbing works. When the panel recommends a screening, insurers have to cover it with no copay. A private plan can choose to pay for a test the panel skipped. Medicare and Medicaid mostly stick to the panel's list. So for older Americans, the panel's list is close to the list of what's free.
The new chair is a pediatric cancer and blood specialist at the Cleveland Clinic. Other appointees include a gastroenterology researcher in Texas, a UCLA cardiologist and a Michigan professor who trains AI to spot heart disease. Past secretaries mostly picked primary-care doctors. The senators' worry, in their letter to Secretary Robert F. Kennedy Jr., is that specialists will push for services inside their own fields. The editorial's answer is that more screening is the point, and that generalists have been slow to adopt new tests. That's the paper's argument. The senators have theirs. We're reporting both.
The prostate test shows how much a grade matters
The editorial's example is the PSA blood test for prostate cancer. The panel recommended against it in 2012, worried about false alarms and slow tumors that never kill. In 2018 it softened, telling doctors to talk the risks over with men ages 55 to 69. It still recommends against the test at 70 and older. The panel also doesn't endorse routine skin-cancer screening. Meanwhile new tests keep arriving. One blood test in development caught stage 1 and 2 pancreatic cancer roughly 87% of the time in a recent study, the editorial notes. Whether a test like that ever becomes free depends on this panel's grade.
Our read
Health Costs. Hold. We don't take a side on who should sit on the panel. We do want you to see the machinery. Free preventive care isn't a law of nature. It's a list, written by a committee, and the list changes when the committee does. In 2012 a PSA test was discouraged. In 2018 it became a conversation. The science moved some, and so did the people reading it.
Your connection is the screening you're due for this year. Pull up your plan's preventive-care page this week, whether that's Medicare, a Medicare Advantage plan or your employer's coverage. Find the test your doctor mentioned, the colonoscopy, the mammogram, the PSA, the skin check. If it isn't on the covered list, call and ask the price before the appointment, because a screening that's off the list can be billed like any other visit. A free test and a surprise bill look identical in the waiting room. You read the forecast before you leave the umbrella at home.